Biotechnology Perspective of Animals Diseases

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture
Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicineMolecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely
To Know More - Biotechnology Perspective of Animals Diseases

Bioinformatics Technologies and Global Markets

BCC Research’s goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ‘omic technologies and computer-enabled technologies that have driven the field forward. It examines the market trends and analysis regarding industry service providers, software solution developers, and IT and bioinformatics service providers that support the pharma industry.
Since the Human Genome Project was completed in April 2003, genome-wide association studies (GWAS) have contributed toward a greater understanding of the genetic basis of complex diseases and advances in high-throughput technologies. This has enabled researchers to rapidly map the genome of vertebrates, invertebrates and pathogens through cost-effective methods.More recently, improvements in cloud computing capabilities and advances in data-analysis software services have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases. Still, the challenge to translate this wealth of information into tangible clinical benefits, to support the development of new therapeutic interventions and to reduce the current prohibitively high cost of drug development remains.
 To Know More - Bioinformatics Technologies and Global Markets

Stem Cell Banking Market in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion

Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) in 2013. The current stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.Many factors have actively contributing towards this overwhelming success stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters. To Know More - Stem Cell Banking Market

Central Nervous System (CNS) Biomarkers

In-depth interviews were conducted with leading experts in the field who are executives in companies, industry analysts and leading individuals in the field.The CNS biomarker and drug markets comprise drug products for treatment of a number of specific diseases afflicting both men and women. For completeness, the current and forecasted markets comprise the total market opportunity for each respective segment.Information to prepare this report was obtained from participating and emerging companies in the biomarker and CNS drug areas and from the following institutes within the National Institutes of Health (NIH): National Institute of Mental Health (NIMH), the National Institute of Aging (NIA), the National Institute of Neurological Diseases and Stroke (NINDS), National Human Genomic Research Institute (NHGRI), the NIH’s Center of Information Technology (CIT) and the National Library of Medicine (NLM).Additional information was obtained from a variety of medical and technical journals on the various specialties within biomarker and CNS applications. Other sources included the New York Times, Wall Street Journal, Washington Post, other newspapers, company documents and Internet websites. Population estimates are based on those reported by the International Data Base of the U.S. Census Bureau. Statistical data was obtained from the World Health Organization (WHO) and the Collaborating Centre for Drug Statistics Methodology (Norway).
To Know More -Central Nervous System (CNS) Biomarkers

India Stem Cell Banking market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million)

Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) in 2013. The current stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.Many factors have actively contributing towards this overwhelming success stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters.

To Know More -India Stem Cell Banking market

Animal Biotechnology - Technologies, Markets

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine
To Know More - Animal Biotechnology - Technologies, Markets

Biotechnology Products Markets in China

China's demand for biotechnology products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
To Know More - Biotechnology Products Markets in China

India Genetic Testing Market

Genetic testing market in India was initially limited to very few organizations in the country, which possessed both the expertise and the capability to conduct screening tests with assurance. The horizon is expanding gradually in the field of identifying DNA and might grow into humungous proportions if growth drivers are properly put into place. More and more laboratories with advanced equipments are now mushrooming to handle the increasing demands and provide people with the test results, as quickly as possible.There has a been a upsurge in the genetic diseases in India with congenital malformations and genetic disorders being the third most common cause of mortality in newborns. Hence there is a need for adequate and effective genetic testing and counselling services. There are multiple reasons for this rise and can be summarized as consanguinity, high birth rate, improved diagnostic facilities, and a lack of expertise in genetic counselling
To Know More -  India Genetic Testing Market.

Top Ten Suppliers of Synthetic Biology Technology

Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.”
These advances also mark an economic turning point, creating a market vision of synthetic life forms and life processes tailored to produce specific substances. The desired yield of such substances as biofuels can be measured in millions of tons, whereas pharmaceuticals can be measured in grams or milligrams.
The door that is opening is likely to affect important markets for decades. Intense research and development continues to be both privately and publically funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.
The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.
To Know More -   Synthetic Biology Technology

Animal Biotechnology Markets and Companies

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture. Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

To Know More - Animal Biotechnology Markets and Companies.

US biotechnology industry revenues have increased from USD 73 billion in 2006 to USD ~ billion in 2011 by growing at a CAGR of ~% during 2006-2011

The report titled ‘The US Biotechnology Market Outlook to 2016 – Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector’ provides a detailed description of the biotechnology market scenario in the US and a comprehensive analysis of the various qualitative and quantitative factors that are influencing the market. The report depicts the size of the biotech industry, biopharmaceuticals, biopesticides and bioseeds, biofuel and bioenzymes segments in the US, a competitive landscape and profiles of key players in these segments and the recent trends and developments in the biotechnology market in the US. The report also covers future outlook and projections for the different segments as well as the overall US biotechnology market on the basis of several industry factors that will shape the growth of this market in next five years.

To Know More : The US Biotechnology Market Outlook to 2016 - Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector

Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016

Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical – Global Trends & Competitive Analysis
The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016. 

To Know More - Ablation Technologies Market (2011-2016) - Global Trends & Competitive Analysis

The Global Biometrics Market in 2012 at $7.59bn.

The unique capabilities of biometric identification technologies provide solutions to a range of security issues for both military and civilian markets. With technological advances now ensuring greater effectiveness, and multi-modular identification systems able to integrate several methods of identification, biometric technology systems are increasingly vital components for the digital age. values the global Biometrics Market in 2012 at $7.59bn.

To Know More - The Biometrics Market 2012-2022

Mesenchymal Stem Cells (MSCs) Increased 112% from 2009 to 2010, and 116% from 2010 to 2011

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

To Know More - Mesenchymal Stem Cells - Advances And Applications

European Directory of Biotechnology Companies 2013

The European Directory of Biotechnology Companies is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 2,000 biotechnology companies and 5,000 executives working in the industry throughout Europe. This powerful Directory is your connection to key decision-makers in the biotechnology industry in Europe.


To Know More -  European Directory of Biotechnology Companies 2013

Biotechnology Industry In India and Highlighting The Scope Of the Bioinformatics Research Market.

The bioinformatics research market in India is poised to become one of the fastest emerging areas in India. Rising R&D activities coupled with the favorable government activities is primarily driving the market. Further, the continual increment in the healthcare expenditure amongst Indians is fueling growth in the market.
To Know More - www.bharatbook.com/BiotechnologyMarket

Directory Of Companies and Executives In The Biotechnology Industry

The USA Directory of Biotechnology Companies 2012-13 is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 2,000 biotechnology companies and 5,000 executives working in the industry throughout the USA. To Know More - www.bharatbook.com/BiotechnologyMarket